Investment
Features
FeesSafety
Academy
More
Pluang+

Evernorth's $1B XRP fund launch on NASDAQ delayed to Oct 12 due to administrative error, not market issues.

Market News
07 Oct 2026
Dailycoin
View Source
Neutral
Evernorth's $1B XRP fund launch on NASDAQ delayed to Oct 12 due to administrative error, not market issues.

Evernorth's $1 billion XRP-only fund, initially set to debut on NASDAQ on October 8, 2026, has been postponed to October 12 due to an administrative delay. This delay does not affect the recent merger approval by Armada II shareholders or the fund's overall status. The treasury holds over 473 million XRP tokens and $300 million in cash equivalents, valuing it above $1 billion. The delay might even benefit the launch if market conditions improve, and the upcoming NASDAQ debut will be closely watched for demand and liquidity.

Regarding XRP’s planned NASDAQ fund launch delay, here is Pluang’s market snapshot as of Oct 07, 2026 23:32 WIB: Among 50 major cryptocurrencies priced on Pluang, 6 rose and 42 fell today. Notable movers include BAL (Balancer) at Rp16.297 with a 1-day change of +11.14%, EGLD (MultiversX) at Rp71.626 down 11.14% with Pluang order activity showing 57% Sell and 43% Buy, and THETA (Theta Network) at Rp3.854 down 10.37% with 100% Sell orders. Typical hold times range from 77 to 85 days.

More News

Hormel Foods price target cut to $23 amid hopes for valuation rebound despite 50% share drop.

Hormel Foods price target cut to $23 amid hopes for valuation rebound despite 50% share drop.

BNP Paribas lowered Hormel Foods' price target from $26 to $23, indicating a potential 16.2% upside from its current price of around $19.80. Despite a 50.5% decline in its share price over five years, Hormel Foods remains attractive for dividend inve...

Analyst Insights
Neutral
2 hours ago
Barclays rates Becton Dickinson 'Underweight' amid $3B U.S. manufacturing partnership

Barclays rates Becton Dickinson 'Underweight' amid $3B U.S. manufacturing partnership

Barclays initiated coverage of Becton, Dickinson and Company (BDX) with an "Underweight" rating, indicating a cautious outlook for the medical technology stock. BDX is partnering with the U.S. government to boost domestic manufacturing and strengthen...

Market News
Bearish
2 hours ago
Morgan Stanley raises Eli Lilly price target to $1,430, signaling 20.8% potential upside.

Morgan Stanley raises Eli Lilly price target to $1,430, signaling 20.8% potential upside.

Morgan Stanley increased its price target for Eli Lilly to $1,430 from $1,419, maintaining an Overweight rating. This new target implies a potential upside of about 20.8% from the current share price of around $1,184. The adjustment reflects updated ...

Analyst Insights
Bullish
3 hours ago
Jito Labs launches JTX, a self-custodial trading platform for pro traders on Solana.

Jito Labs launches JTX, a self-custodial trading platform for pro traders on Solana.

Jito Labs has introduced JTX, a new self-custodial trading platform on the Solana blockchain. The platform supports spot trading of tokens, memecoins, tokenized equities, and ETFs, providing professional-grade execution tools. This launch aims to emp...

Protocol Fundamentals
Bullish
4 hours ago
Bitcoin and gold prices fall amid Fed rate hike and geopolitical concerns

Bitcoin and gold prices fall amid Fed rate hike and geopolitical concerns

Bitcoin dropped near $83,000 after failing to surpass $87,200, while spot gold tested the $4,100 level following the Federal Reserve's unanimous decision to raise interest rates by 25 basis points to 3.75%-4%. The Fed cited solid economic growth but ...

Market News
Neutral
4 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App